Medical Condition News

RSS

Four-year Johns Hopkins program provides efficient, less expensive care for patients in East Baltimore

When people with chronic health problems couldn't get around town to their doctors' appointments, a four-year Johns Hopkins program brought the appointments to them.

25 Dec 2016

Sight Sciences receives Health Canada approval for TRAB 360 Trabeculotomy System

Sight Sciences, Inc., a venture-backed, commercial-stage ophthalmic medical device company announced today that it has received Health Canada approval for the TRAB 360 Trabeculotomy System.

23 Dec 2016

OTC medical device receives CE Mark approval to treat pain linked to fibromyalgia

AVACEN Medical announced its AVACEN 100, Class-IIa, OTC medical device has received the CE Mark approval to treat widespread pain associated with fibromyalgia.

23 Dec 2016

Study shows three-drug combination delays recurrence and lengthens life for myeloma patients

The International Myeloma Foundation today announced the publication in The Lancet of the results of a randomized, phase III trial, conducted by SWOG, a publicly funded international cancer clinical trials network, and led by IMF chairman of the board Brian G.M. Durie, MD.

23 Dec 2016

DDF launches three grants to fund opportunities for gastric cancer research

Debbie's Dream Foundation: Curing Stomach Cancer, an international non-profit organization that raises awareness and funds for stomach cancer, launched three research grants totaling $300,000 for the 2016-2017 grant cycle.

23 Dec 2016

Inherited CD70 deficiency increases susceptibility to Epstein-Barr virus and EBV-related cancer

Investigators at the National Institutes of Health and international colleagues have identified a genetic immune disorder characterized by increased susceptibility and poor immune control of Epstein-Barr virus (EBV) and, in some cases, an EBV-associated cancer called Hodgkin's lymphoma.

23 Dec 2016

FDA approves first drug to treat children and adults with spinal muscular atrophy

The U.S. Food and Drug Administration today approved Spinraza (nusinersen), the first drug approved to treat children and adults with spinal muscular atrophy (SMA), a rare and often fatal genetic disease affecting muscle strength and movement.

23 Dec 2016

Researchers find increase in heart attacks during Christmas holidays

University of Melbourne researchers have found an increase in heart attacks around the festive period may be due to more difficult access to hospitals, combined with stress, an excess of alcohol and a fatty diet.

23 Dec 2016

UCLA-led consortium receives $8.6 million NIH grant to map the heart's nervous system

A consortium directed by UCLA's Dr. Kalyanam Shivkumar has received a three-year, $8.6 million grant from the National Institutes of Health to map the heart's nervous system.

23 Dec 2016

UCLA-led research finds promising results for more personalized head and neck cancer treatment

Researchers have found that people with advanced head and neck squamous cell carcinoma and the KRAS-variant inherited genetic mutation have significantly improved survival when given a short course of the drug cetuximab in combination with standard chemotherapy and radiation.

23 Dec 2016

FDA approves Dexcom’s G5 Mobile CGM system for diabetes management

Dexcom, Inc., the leader in continuous glucose monitoring (CGM) for patients with diabetes, announced today that the U.S. Food and Drug Administration has approved its G5 Mobile CGM system as the first and only continuous glucose monitoring system that can be used to make daily diabetes treatment decisions without finger pricking.

23 Dec 2016

Cycle Pharmaceuticals receives license for IP on PARP inhibitor drugs for treating vascular disease

Cambridge Enterprise has exclusively licensed intellectual property relating to the use of PARP inhibitor drugs for treating vascular disease to CYCLE Pharmaceuticals.

23 Dec 2016

Cedars-Sinai expert explains how to recognize signs and symptoms of stroke during the holidays

Along with increased cheer and festivities during the holidays comes an increased risk of stroke, one of the leading causes of death and disability in the U.S.

23 Dec 2016

Researchers working to develop pill for inherited bleeding disorders

Motivated by the tribulations of hemophilia patients and their families, researchers funded by the National Institute of Biomedical Imaging and Bioengineering are working to develop a pill to treat this serious inherited bleeding disorder.

23 Dec 2016

LifePoint Health earns Chest Pain Center Accreditation for 35 facilities

Thirty-five LifePoint Health facilities earned Chest Pain Center Accreditation in 2016, bringing the total number of accredited facilities to 63, as part of a system-wide collaboration between LifePoint Health and the American College of Cardiology.

23 Dec 2016

Study reveals impact of histology on SBRT treatment in early-stage NSCLC patients

Early-stage non-small cell lung cancer (NSCLC) patients with squamous cell carcinoma (SqCC) have a significantly higher rate of local failure after stereotactic body radiation therapy (SBRT) than other NSCLC histological subtypes.

23 Dec 2016

UC researchers uncover obesity-related protein's role in leukemia development

Cancer researchers at the University of Cincinnati College of Medicine have found an obesity-associated protein's role in leukemia development and drug response which could lead to more effective therapies for the illness.

22 Dec 2016

Scientists discover OGDHL and NRD1 genes linked to progressive loss of neurological function

An international team of scientists has discovered that the gene, OGDHL, a key protein required for normal function of the mitochondria -- the energy-producing factory of the cell -- and its chaperone, nardilysin (NRD1) are linked to progressive loss of neurological function in humans.

22 Dec 2016

Making muscles burn more fat and less glucose could cause diabetes, say researchers

Making muscles burn more fat and less glucose can increase exercise endurance, but could simultaneously cause diabetes, says a team of scientists from Baylor College of Medicine and other institutions.

22 Dec 2016

New computational tool can predict personal cancer driver genes to optimize treatment

Columbia University Medical Center researchers have created a computational tool that can rapidly predict which genes are implicated in an individual's cancer and recommend treatments.

22 Dec 2016

Medical Condition News

Four-year Johns Hopkins program provides efficient, less expensive care for patients in East Baltimore

Sight Sciences receives Health Canada approval for TRAB 360 Trabeculotomy System

OTC medical device receives CE Mark approval to treat pain linked to fibromyalgia

Study shows three-drug combination delays recurrence and lengthens life for myeloma patients

DDF launches three grants to fund opportunities for gastric cancer research

Inherited CD70 deficiency increases susceptibility to Epstein-Barr virus and EBV-related cancer

FDA approves first drug to treat children and adults with spinal muscular atrophy

Researchers find increase in heart attacks during Christmas holidays

UCLA-led consortium receives $8.6 million NIH grant to map the heart's nervous system

UCLA-led research finds promising results for more personalized head and neck cancer treatment

FDA approves Dexcom’s G5 Mobile CGM system for diabetes management

Cycle Pharmaceuticals receives license for IP on PARP inhibitor drugs for treating vascular disease

Cedars-Sinai expert explains how to recognize signs and symptoms of stroke during the holidays

Researchers working to develop pill for inherited bleeding disorders

LifePoint Health earns Chest Pain Center Accreditation for 35 facilities

Study reveals impact of histology on SBRT treatment in early-stage NSCLC patients

UC researchers uncover obesity-related protein's role in leukemia development

Scientists discover OGDHL and NRD1 genes linked to progressive loss of neurological function

Making muscles burn more fat and less glucose could cause diabetes, say researchers

New computational tool can predict personal cancer driver genes to optimize treatment

Building quality into drug development for safer, faster medicines

How Pulp Fixin Is Turning Paper into High-Performance Sustainable Labware

A new method to measure intracellular water in biological systems

Latest News